Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.87
Delayed Data
As of Sep 03
 +0.0026 / +0.30%
Today’s Change
0.41
Today|||52-Week Range
1.59
+19.18%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.87
Today’s open0.89
Day’s range0.85 - 0.92
Volume26,037
Average volume (3 months)170,790
Market cap$121.8M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)+28.36%
Earnings growth (this year)-4.17%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.83

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc+0.69+5.23%
FBIOFortress Biotech Inc-0.06-2.33%
EPRSEPIRUS Biopharmaceut...+0.02+0.39%
JNPJuniper Pharmaceutic...+1.39+11.82%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$39.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Marc Steven Hanover
CFO, CAO, Accounting Director &
Controller
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers